These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2427849

  • 1. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP, Khandwala A, Wolf PS, Grebow P, Wong L.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [Abstract] [Full Text] [Related]

  • 2. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H.
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [Abstract] [Full Text] [Related]

  • 3. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG, Khandwala A, Weinryb I, Pruss TP, Neiss E, Sutherland CA.
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR, Smith RD, Wolf PS, Russ TP.
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [Abstract] [Full Text] [Related]

  • 5. Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator.
    Perrone MH, Barrett JA.
    Am Heart J; 1991 Feb; 121(2 Pt 2):677-83. PubMed ID: 1671187
    [Abstract] [Full Text] [Related]

  • 6. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
    Smith RD, Cobuzzi A, Wolf PS, Pruss TP.
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
    [Abstract] [Full Text] [Related]

  • 7. Mechanistic studies on the "bronchosparing" activity of celiprolol, a cardioselective beta-adrenoceptor antagonist.
    Van Inwegen RG, Khandwala A, Gordon RJ, Sutherland CA, Wolf P, Pruss TP.
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):127-44. PubMed ID: 2881517
    [Abstract] [Full Text] [Related]

  • 8. Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol.
    Opie LH.
    Am J Cardiol; 1988 Feb 10; 61(5):8C-13C. PubMed ID: 2893535
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct 10; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 12. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H.
    Arch Int Pharmacodyn Ther; 1987 Feb 10; 285(2):199-210. PubMed ID: 2883946
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ.
    Am J Cardiol; 1988 Feb 10; 61(5):14C-22C. PubMed ID: 2893531
    [Abstract] [Full Text] [Related]

  • 14. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ, Harting J.
    J Cardiovasc Pharmacol; 1984 Feb 10; 6(6):1156-60. PubMed ID: 6084774
    [Abstract] [Full Text] [Related]

  • 15. [Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
    Beil M, Ulmer WT.
    Arzneimittelforschung; 1977 Feb 10; 27(2):419-22. PubMed ID: 324487
    [Abstract] [Full Text] [Related]

  • 16. Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dog.
    Mann WS, Sales EF, Van Inwegen RG, Barrett JA, Smith RD, Wolf PS.
    Arch Int Pharmacodyn Ther; 1986 Nov 10; 284(1):53-71. PubMed ID: 2881519
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of celiprolol.
    Louis WJ, Drummer OH, Tung LH.
    Cardiovasc Drugs Ther; 1991 Jan 10; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R, Zoppi A, Tettamanti F, Poletti L, Rizzardi G, Fiocchi G.
    Cardiovasc Drugs Ther; 1990 Aug 10; 4(4):1145-9. PubMed ID: 1982059
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G, Grimes D, Muirhead C, Oshiro G.
    Can J Physiol Pharmacol; 1984 Jun 10; 62(6):610-6. PubMed ID: 6146394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.